Presentation TCT 2016 Unprotected Left Main and Multivessel Transradial PCI Presenter: Vladimir Dzavik October 30, 2016 REGISTER for free or LOG IN to view this content Coronary Presentation TCT 2016 Vascular Access/Closure Up Next Presentation TCT 2016 LEADERS FREE: Two-Year Clinical and Subgroup Outcomes From a Prospective, Randomized Trial of a Polymer-Free Drug-Coated Stent and a Bare Metal Stent in Patients With Coronary Artery Disease at High Bleeding Risk Presenter: Philip M. Urban October 30, 2016 More slides + Presentation TCT 2016 ABSORB II: Three-Year Clinical Outcomes From a Prospective, Randomized Trial of an Everolimus-Eluting Bioresorbable Vascular Scaffold vs an Everolimus-Eluting Metallic Stent in Patients With Coronary Artery Disease Presenter: Patrick W. Serruys October 30, 2016 Presentation TCT 2016 ABSORB China: Two-Year Clinical Outcomes From a Prospective, Randomized Trial of an Everolimus-Eluting Bioresorbable Vascular Scaffold vs an Everolimus-Eluting Metallic Stent in Patients With Coronary Artery Disease Presenter: Runlin Gao October 30, 2016 We Recommend
Presentation TCT 2016 LEADERS FREE: Two-Year Clinical and Subgroup Outcomes From a Prospective, Randomized Trial of a Polymer-Free Drug-Coated Stent and a Bare Metal Stent in Patients With Coronary Artery Disease at High Bleeding Risk Presenter: Philip M. Urban October 30, 2016
Presentation TCT 2016 ABSORB II: Three-Year Clinical Outcomes From a Prospective, Randomized Trial of an Everolimus-Eluting Bioresorbable Vascular Scaffold vs an Everolimus-Eluting Metallic Stent in Patients With Coronary Artery Disease Presenter: Patrick W. Serruys October 30, 2016
Presentation TCT 2016 ABSORB China: Two-Year Clinical Outcomes From a Prospective, Randomized Trial of an Everolimus-Eluting Bioresorbable Vascular Scaffold vs an Everolimus-Eluting Metallic Stent in Patients With Coronary Artery Disease Presenter: Runlin Gao October 30, 2016